ICIs blocked inhibitory immune checkpoints such as PD-1, PD-L1, and CTLA-4 to reboot the cancer-immunity cycle (CIC) and prevent tumor immune evasion, thus restoring and maintaining anti-tumor immunity. This evidence concerns the gene CTLA4 and neoplasm.